ADST Technologies
Mass Injection Devices
Company Overview
Snapshot
Founded in September 2013 by Shaul Wolfstein, ADST Technologies operates with 1–10 employees. The company developed an automated, safe, and sterile device for mass vaccination. ADST Technologies ceased operations in May 2022.
Business overview
ADST Technologies specializes in Health Tech & Life Sciences, developing medical devices for mass vaccination. Their core product is a disposable syringe device designed to prevent disease spread by automatically replacing needles after each injection, ensuring sterility. The device also features an internal disinfection mode and meets IP65 standards for external sterilization. The company serves markets within public health, animal health, and veterinary sectors, targeting clinics, hospitals, and livestock industries with solutions for disease management and vaccine administration.
Log in to access full profile ›Company Intelligence Q&A
- What is ADST Technologies' primary product?
- ADST Technologies developed a disposable syringe device for mass vaccination, designed to be automated, safe, and sterile by automatically replacing needles after each injection.
- When was ADST Technologies founded?
- ADST Technologies was founded in September 2013.
- What is the operational status of ADST Technologies?
- ADST Technologies is currently non-active and ceased operations in May 2022.
- Who is a co-founder of ADST Technologies?
- Shaul Wolfstein is a co-founder of ADST Technologies.
- What industries does ADST Technologies serve?
- ADST Technologies serves the public health, animal health, and veterinary industries, including clinics, hospitals, and livestock sectors.